UBS Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $597M | Buy |
2,022,656
+140,840
| +7% | +$41.8M | 0.09% | 224 |
|
|
2025
Q4 | $514M | Sell |
1,881,816
-1,017,014
| -35% | -$276M | 0.08% | 228 |
|
|
2025
Q3 | $783M | Sell |
2,898,830
-21,151
| -0.7% | -$5.75M | 0.12% | 146 |
|
|
2025
Q2 | $805M | Sell |
2,919,981
-30,179
| -1% | -$8.21M | 0.14% | 135 |
|
|
2025
Q1 | $783M | Buy |
2,950,160
+271,026
| +10% | +$66.9M | 0.14% | 130 |
|
|
2024
Q4 | $622M | Buy |
2,679,134
+854,957
| +47% | +$197M | 0.12% | 167 |
|
|
2024
Q3 | $403M | Buy |
1,824,177
+162,827
| +10% | +$33.7M | 0.09% | 216 |
|
|
2024
Q2 | $327M | Buy |
1,661,350
+13,873
| +0.8% | +$2.87M | 0.08% | 239 |
|
|
2024
Q1 | $355M | Buy |
1,647,477
+2,991
| +0.2% | +$628K | 0.09% | 224 |
|
|
2023
Q4 | $346M | Buy |
1,644,486
+117,229
| +8% | +$25M | 0.1% | 193 |
|
|
2023
Q3 | $306M | Buy |
1,527,257
+120,552
| +9% | +$24M | 0.11% | 190 |
|
|
2023
Q2 | $261M | Buy |
1,406,705
+134,794
| +11% | +$24.9M | 0.09% | 237 |
|
|
2023
Q1 | $244M | Sell |
1,271,911
-366,054
| -22% | -$66.2M | 0.09% | 216 |
|
|
2022
Q4 | $275M | Buy |
1,637,965
+485,459
| +42% | +$84.4M | 0.1% | 205 |
|
|
2022
Q3 | $204M | Sell |
1,152,506
-77,386
| -6% | -$15.3M | 0.09% | 228 |
|
|
2022
Q2 | $252M | Sell |
1,229,892
-33,218
| -3% | -$7.04M | 0.1% | 210 |
|
|
2022
Q1 | $300M | Buy |
1,263,110
+128,697
| +11% | +$30.2M | 0.1% | 211 |
|
|
2021
Q4 | $259M | Sell |
1,134,413
-152,651
| -12% | -$33.6M | 0.07% | 279 |
|
|
2021
Q3 | $249M | Sell |
1,287,064
-75,017
| -6% | -$15.2M | 0.08% | 255 |
|
|
2021
Q2 | $290M | Sell |
1,362,081
-132,711
| -9% | -$28M | 0.09% | 217 |
|
|
2021
Q1 | $305M | Sell |
1,494,792
-77,055
| -5% | -$15.2M | 0.1% | 202 |
|
|
2020
Q4 | $286M | Buy |
1,571,847
+118,006
| +8% | +$20.1M | 0.1% | 225 |
|
|
2020
Q3 | $243M | Buy |
1,453,841
+207,683
| +17% | +$35M | 0.09% | 218 |
|
|
2020
Q2 | $203M | Sell |
1,246,158
-13,809
| -1% | -$2.48M | 0.09% | 230 |
|
|
2020
Q1 | $218M | Sell |
1,259,967
-139,176
| -10% | -$27.7M | 0.1% | 197 |
|
|
2019
Q4 | $281M | Sell |
1,399,143
-159,248
| -10% | -$32.7M | 0.1% | 202 |
|
|
2019
Q3 | $329M | Sell |
1,558,391
-25,822
| -2% | -$5.4M | 0.13% | 167 |
|
|
2019
Q2 | $308M | Sell |
1,584,213
-66,080
| -4% | -$12.2M | 0.12% | 175 |
|
|
2019
Q1 | $272M | Buy |
1,650,293
+15,179
| +0.9% | +$2.68M | 0.11% | 189 |
|
|
2018
Q4 | $308M | Buy |
1,635,114
+198,163
| +14% | +$36.6M | 0.14% | 162 |
|
|
2018
Q3 | $245M | Buy |
1,436,951
+52,976
| +4% | +$8.92M | 0.1% | 212 |
|
|
2018
Q2 | $227M | Sell |
1,383,975
-248,904
| -15% | -$40.7M | 0.1% | 213 |
|
|
2018
Q1 | $264M | Sell |
1,632,879
-147,618
| -8% | -$23.5M | 0.11% | 198 |
|
|
2017
Q4 | $260M | Buy |
1,780,497
+239,963
| +16% | +$34.2M | 0.11% | 205 |
|
|
2017
Q3 | $209M | Buy |
1,540,534
+76,195
| +5% | +$9.63M | 0.1% | 220 |
|
|
2017
Q2 | $183M | Buy |
1,464,339
+246,770
| +20% | +$29.5M | 0.09% | 229 |
|
|
2017
Q1 | $145M | Buy |
1,217,569
+219,207
| +22% | +$26.4M | 0.08% | 264 |
|
|
2016
Q4 | $115M | Buy |
998,362
+3,165
| +0.3% | +$352K | 0.06% | 297 |
|
|
2016
Q3 | $104M | Sell |
995,197
-5,761
| -0.6% | -$601K | 0.06% | 307 |
|
|
2016
Q2 | $97.5M | Sell |
1,000,958
-96,414
| -9% | -$9.11M | 0.06% | 312 |
|
|
2016
Q1 | $105M | Sell |
1,097,372
-23,122
| -2% | -$2.1M | 0.07% | 266 |
|
|
2015
Q4 | $102M | Buy |
1,120,494
+95,090
| +9% | +$8.95M | 0.07% | 295 |
|
|
2015
Q3 | $95.1M | Sell |
1,025,404
-143,558
| -12% | -$13.6M | 0.07% | 292 |
|
|
2015
Q2 | $109M | Sell |
1,168,962
-149,091
| -11% | -$13.9M | 0.07% | 290 |
|
|
2015
Q1 | $125M | Sell |
1,318,053
-53,880
| -4% | -$4.99M | 0.09% | 242 |
|
|
2014
Q4 | $122M | Buy |
+1,371,933
| New | +$116M | 0.09% | 250 |
|
Other funds holding CME
VCM
VPM
UBS Group's CME Position: Q1 2026 in Review
UBS Group increased its CME Group (CME) stake by 7.5% in Q1 2026, buying an estimated $41.8M and bringing the position to 2,022,656 shares worth $597M. The position accounts for 0.09% of the portfolio, ranked #224.
UBS Group first reported a position in CME in Q4 2014 and has held it in 46 quarters since. The position peaked at $805M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- UBS Group held 2,022,656 shares of CME Group worth $597M as of Q1 2026.
- UBS Group bought 140,840 CME Group shares in Q1 2026, an estimated $41.8M.
- CME Group made up 0.09% of UBS Group's portfolio in Q1 2026, its #224 holding.
- UBS Group first reported a position in CME Group in Q4 2014 and has held it in 46 quarters since.
- UBS Group's CME Group position peaked at $805M in Q2 2025.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.